Interpace Biosciences Inc (IDXG)
Healthcare • Diagnostics & Research
StockOTC Markets OTCIDUnited StatesUS46062X4025
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Interpace Biosciences Inc, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:36. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 14 Nov 2022 16:00 | -1.25 | -1.24 | +0.7% | In line |
| 15 Aug 2022 16:00 | -2.60 | -4.95 | -90.5% | Miss |
| 16 May 2022 16:00 | -4.00 | -2.71 | +32.3% | Beat |
| 31 Mar 2022 16:00 | -1.30 | -4.51 | -247.2% | Miss |
| 10 Nov 2021 16:00 | -3.10 | -3.91 | -26.1% | Miss |
| 10 Aug 2021 16:00 | -2.40 | -3.17 | -31.9% | Miss |
| 11 May 2021 16:00 | -7.15 | -3.50 | +51.1% | Beat |
| 31 Mar 2021 17:00 | -6.60 | -7.80 | -18.2% | Miss |
| 20 Jan 2021 06:00 | -6.33 | -7.65 | -20.8% | Miss |
| 19 Oct 2020 17:00 | -7.39 | -6.75 | +8.7% | Beat |
| 25 Jun 2020 16:00 | -6.20 | -6.48 | -4.6% | Miss |
| 22 Apr 2020 11:00 | -4.10 | -34.24 | -735.1% | Miss |
| 13 Nov 2019 16:00 | -4.60 | -8.45 | -83.7% | Miss |
| 13 Aug 2019 08:00 | -3.10 | -6.98 | -125.3% | Miss |
| 13 May 2019 16:00 | -2.80 | -4.78 | -70.9% | Miss |
| 19 Mar 2019 16:00 | -4.10 | -5.04 | -23.1% | Miss |
| 13 Nov 2018 16:00 | -3.70 | -4.75 | -28.5% | Miss |
| 09 Aug 2018 16:00 | -4.50 | -3.34 | +25.7% | Beat |
| 15 May 2018 08:00 | -3.75 | -5.76 | -53.7% | Miss |
| 15 Mar 2018 16:00 | -5.17 | -5.50 | -6.5% | Miss |
| 13 Nov 2017 08:00 | -13.00 | -7.50 | +42.3% | Beat |
| 12 Nov 2015 16:00 | -240.00 | -123.55 | +48.5% | Beat |
| 13 Aug 2015 16:00 | -210.00 | -188.35 | +10.3% | Beat |
| 12 May 2015 16:00 | -240.00 | -95.55 | +60.2% | Beat |
| 03 Mar 2015 16:00 | -242.50 | -206.50 | +14.9% | Beat |
| 03 Nov 2014 06:00 | -85.00 | -145.00 | -70.6% | Miss |
| 13 Aug 2014 16:00 | -60.00 | -85.00 | -41.7% | Miss |
| 07 May 2014 16:00 | -68.33 | -55.00 | +19.5% | Beat |
| 27 Feb 2014 16:00 | -53.33 | -125.00 | -134.4% | Miss |
| 12 Nov 2013 16:00 | -93.33 | -70.00 | +25.0% | Beat |
| 05 Aug 2013 16:00 | -48.33 | -30.00 | +37.9% | Beat |
| 13 May 2013 16:00 | -55.00 | 75.00 | +236.4% | Beat |
| 06 Mar 2013 16:00 | -15.00 | 9.65 | +164.3% | Beat |
| 05 Nov 2012 16:00 | -20.00 | -30.00 | -50.0% | Miss |
| 13 Aug 2012 16:00 | -25.00 | -15.00 | +40.0% | Beat |
| 14 May 2012 16:00 | 5.00 | -10.00 | -300.0% | Miss |
| 07 Mar 2012 16:00 | 5.00 | 16.10 | +222.0% | Beat |
| 09 Nov 2011 18:00 | -22.50 | -5.00 | +77.8% | Beat |
| 08 Aug 2011 16:00 | -55.00 | -30.00 | +45.5% | Beat |
| 03 May 2011 16:00 | -45.00 | -20.00 | +55.6% | Beat |
| 21 Mar 2011 16:00 | 10.00 | -50.00 | -600.0% | Miss |
| 03 Nov 2010 06:00 | -55.00 | 15.00 | +127.3% | Beat |
| 04 Aug 2010 16:00 | -100.00 | -10.00 | +90.0% | Beat |
| 06 May 2010 16:00 | -45.00 | -60.00 | -33.3% | Miss |
| 04 Mar 2010 16:00 | -90.00 | -50.00 | +44.4% | Beat |
| 05 Nov 2009 16:00 | -175.00 | -95.00 | +45.7% | Beat |
| 05 Aug 2009 16:00 | -200.00 | -195.00 | +2.5% | Beat |
| 11 Mar 2009 16:00 | -350.00 | -630.00 | -80.0% | Miss |
| 06 Nov 2008 16:00 | -345.00 | -320.00 | +7.3% | Beat |
| 06 Aug 2008 16:00 | -250.00 | -265.00 | -6.0% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 38.7M | -17.5% | 24.6M | 63.5% | 4.45 | +122.5% | 5.5M |
| 2024 | 46.9M | +17.2% | 6.7M | 14.3% | 2.00 | +122.2% | 3.8M |
| 2023 | 40M | +25.7% | 2M | 4.9% | 0.90 | +103.5% | 3.3M |
| 2022 | 31.8M | — | -22M | -69.0% | -25.90 | — | -8M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 6.20 | 6.25 | 6.20 | 6.20 | -6.06% | 1,800 | |
| 11 Nov 2026 | 6.60 | 6.60 | 6.60 | 6.60 | -5.71% | 100 | |
| 10 Nov 2026 | 7.00 | 7.00 | 7.00 | 7.00 | 0.00% | — | |
| 09 Nov 2026 | 7.00 | 7.00 | 7.00 | 7.00 | 0.00% | — | |
| 06 Nov 2026 | 6.06 | 7.00 | 6.06 | 7.00 | 0.00% | 300 | |
| 05 Nov 2026 | 5.74 | 7.45 | 5.74 | 7.00 | +22.38% | 2,100 | |
| 04 Nov 2026 | 5.46 | 5.72 | 5.45 | 5.72 | +5.09% | 2,500 | |
| 03 Nov 2026 | 5.44 | 5.44 | 5.44 | 5.44 | 0.00% | — | |
| 02 Nov 2026 | 5.44 | 5.44 | 5.44 | 5.44 | -2.68% | 200 | |
| 30 Oct 2026 | 5.59 | 5.59 | 5.59 | 5.59 | -2.22% | 500 | |
| 18 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
Key data
- Previous close
- 6.60 USD
- Market cap
- 36.6M
- Exchange
- OTC Markets OTCID
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 11.2 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 16.7 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 20.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 15.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 3.5 / 10 No figures for this part: it counts as a cautious 35%. | — |
- Thinly traded: about 23,132 a day
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 85% of the figures (grade B). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 1.48× | Good | 30.56× |
| P/E (forward) | -41.67× | Weak | 14.16× |
| Price / book | 1.49× | Good | 3.5× |
| Price / sales | 1.02× | Good | 3.33× |
| EV / EBITDA | 7.02× | Good | 11.19× |
| Free cash flow yield | 9.3% | Good | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 63.7% | Good | 54.9% |
| Operating margin | 11.6% | Fair | 5.8% |
| Net margin | 67.6% | Good | 1.2% |
| Return on equity | 225.7% | Good | 4.4% |
| Return on assets | 11.1% | Good | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 6.7% | Fair | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.04× | Good | 0.4× |
| Net debt / EBITDA | -0.37× | Good | 1.46× |
| Interest cover | 24.31× | Good | 2.17× |
| Current ratio | 2.22× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow IDXG and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.